Multiply Labs Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 65

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $75M

  • Investors
  • 40

Multiply Labs General Information

Description

Manufacturer of robotic systems intended to automate biological therapy manufacturing processes. The company offers robotic clusters, automated instrument integration, sterile processing equipment, and process monitoring software, enabling pharmaceutical and biotechnology companies to automate production workflows and maintain manufacturing consistency.

Contact Information

Formerly Known As
PharmaCube
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1426 Minnesota Street
  • San Francisco, CA 94107
  • United States
+1 (615)
Primary Industry
Other Hardware
Other Industries
Other Healthcare Technology Systems
Biotechnology
Other Devices and Supplies
Corporate Office
  • 1426 Minnesota Street
  • San Francisco, CA 94107
  • United States
+1 (615)

Multiply Labs Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Multiply Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 02-Nov-2026 $75M Completed Generating Revenue
7. Later Stage VC 24-Sep-2024 Completed Generating Revenue
6. Later Stage VC 21-Apr-2023 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Later Stage VC (Series A) 20-Apr-2021 Completed Generating Revenue
3. Accelerator/Incubator 22-Aug-2016 Completed Startup
2. Grant $5K Completed Startup
1. University Spin-Out 01-Jan-2016 Completed Startup
To view Multiply Labs’s complete valuation and funding history, request access »

Multiply Labs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-10
Series A-9
Series A-8
Series A-7
Series A-6
Series A-5
Series A-4
Series A-3
Series A-2 451,210 $0.000010 $0.5 $0.5 1x $0.5 1.67%
Series A-1 389,935 $0.000010 $0.45 $0.45 1x $0.45 1.45%
To view Multiply Labs’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Multiply Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of robotic systems intended to automate biological therapy manufacturing processes. The company offers robo
Other Hardware
San Francisco, CA
65 As of 2026

London, United Kingdom
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Multiply Labs Competitors (5)

One of Multiply Labs’s 5 competitors is Ori Biotech, a Venture Capital-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ori Biotech Venture Capital-Backed London, United Kingdom
Cellares Venture Capital-Backed South San Francisco, CA
Fabrx Accelerator/Incubator Backed London, United Kingdom
Cellino Venture Capital-Backed Cambridge, MA
Byondis Corporation Nijmegen, Netherlands
You’re viewing 5 of 5 competitors. Get the full list »

Multiply Labs Patents

Multiply Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260265672-A1 Systems, methods, and devices for automated cellular therapy manufacturing and liquid control Pending 05-Mar-2025
US-20250224858-A1 Systems, methods, and devices for automated cellular therapy manufacturing through graphical user interface Pending 08-Jan-2024
US-12479112-B2 Apparatus for facilitating automated connection Active 05-Jan-2024
US-12703108-B2 Apparatus for facilitating automated connection Active 05-Jan-2024
US-20250224059-A1 Apparatus for facilitating automated connection Active 05-Jan-2024 G01N35/0099
To view Multiply Labs’s complete patent history, request access »

Multiply Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Multiply Labs Investors (40)

Investor Name Investor Type Holding Investor Since Participating Rounds
AstraZeneca Corporation Minority
Lingotto Hedge Fund Minority
NantWorks VC-Backed Company Minority
Ora Global Venture Capital Minority
Strange Ventures Venture Capital Minority
You’re viewing 5 of 40 investors. Get the full list »

Multiply Labs FAQs

  • When was Multiply Labs founded?

    Multiply Labs was founded in 2016.

  • Where is Multiply Labs headquartered?

    Multiply Labs is headquartered in San Francisco, CA.

  • What is the size of Multiply Labs?

    Multiply Labs has 65 total employees.

  • What industry is Multiply Labs in?

    Multiply Labs’s primary industry is Other Hardware.

  • Is Multiply Labs a private or public company?

    Multiply Labs is a Private company.

  • What is Multiply Labs’s current revenue?

    The current revenue for Multiply Labs is .

  • How much funding has Multiply Labs raised over time?

    Multiply Labs has raised $111M.

  • Who are Multiply Labs’s investors?

    AstraZeneca, Lingotto, NantWorks, Ora Global, and Strange Ventures are 5 of 40 investors who have invested in Multiply Labs.

  • Who are Multiply Labs’s competitors?

    Ori Biotech, Cellares, Fabrx, Cellino, and Byondis are competitors of Multiply Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process